Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.95B 5,873B | Sales 2025 * | 16.52B 6,084B | Capitalization | 18.8B 6,924B |
---|---|---|---|---|---|
Net income 2024 * | 820M 302B | Net income 2025 * | 1.39B 511B | EV / Sales 2024 * | 2.12 x |
Net Debt 2024 * | 14.93B 5,497B | Net Debt 2025 * | 12.41B 4,570B | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
17.7
x | P/E ratio 2025 * |
12.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.44% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 59 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+37.69% | 727B | |
-7.91% | 354B | |
+15.64% | 328B | |
-0.45% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.79% | 164B | |
-2.07% | 164B |